Table of Content

Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Innovations And Developments
4.1.2. Restraints
4.1.2.1. High Developmental Cost.
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
7.1.2. Market Attractiveness Index, By Product Type Segment
7.2. Instruments
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.2.2.1. Outright Purchase
7.2.2.2. Rental Purchase
7.3. Reagents & Kits
7.3.1. NAT Reagents & Kits
7.3.1.1. Standards and Controls
7.3.1.2. Labeling and Detection Reagents
7.3.1.3. Enzymes and Polymerases
7.3.1.4. Probes and Primers
7.3.1.5. Buffers, Nucleotides and Solutions
7.3.2. ELISA Reagents & Kits
7.3.2.1. Conjugates (Antigen Or Antibody-Conjugated Enzyme)
7.3.2.2. Immunosorbents
7.3.2.3. Controls
7.3.2.4. Substrates
7.3.2.5. Sample Diluents and Wash Solutions
7.3.3. Other Reagents
7.4. Software and Services
8. By Test Type
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type Segment
8.1.2. Market Attractiveness Index, By Test Type Segment
8.2. Complete Blood Count
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Basic Metabolic Panel
8.4. Blood Enzyme Tests
8.5. Blood Clotting Tests
8.6. Blood Cholesterol Tests
9. By Technology
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
9.1.2. Market Attractiveness Index, By Technology Segment
9.2. Next-Generation Sequencing (NGS)
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Nucleic Acid Test (NAT)
9.3.1. Real-Time Polymerase Chain Reaction (PCR)
9.3.2. Transcription-Mediated Amplification (TMA)
9.4. Enzyme-Linked Immunosorbent Assay (ELISA)
9.4.1. ELISA, By Platform
9.4.1.1. Fluorescence Immunoassay (FIA)
9.4.1.2. Chemiluminescence Immunoassay (CLIA)
9.4.1.3. Colorimetric Immunoassay (CI)
9.4.2. ELISA, By Generation
9.4.2.1. First-Generation ELISA
9.4.2.2. Second-Generation ELISA
9.4.2.3. Third-Generation ELISA
9.4.2.4. Fourth-Generation & Above
9.5. Western Blot Assay
9.6. Rapid Tests
9.7. Others
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
10.1.2. Market Attractiveness Index, By End User Segment
10.2. Hospitals And Clinics
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Diagnostic Centers
10.4. Blood Banks
10.5. Other
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. The U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. The U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Product Benchmarking
13. Company Profiles
13.1. Chembio Diagnostics, Inc.
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Bio-Rad Laboratories Inc.
13.3. Grifols
13.4. Abbott Laboratories
13.5. F. Hoffmann-La Roche
13.6. Siemens Healthineers
13.7. Biom?rieux
13.8. Thermo Fisher Scientific, Inc.
13.9. Ortho Clinical Diagnostics, Inc.
13.10. Becton, Dickinson and Company
13.11. Danaher Corporation
LIST NOT EXHAUSTIVE
14. DataM
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us